Stockscreener 앱 받기
25.86
4.19%
1.04
시간 외 거래:
25.86
전일 마감가:
$24.82
열려 있는:
$24.96
하루 거래량:
241.60K
Relative Volume:
0.79
시가총액:
$1.51B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+12.43%
1개월 성능:
-4.68%
6개월 성능:
+56.25%
1년 성능:
+0.00%
1일 변동 폭
$24.64
$26.00
1주일 범위
$22.68
$26.00
52주 변동 폭
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
명칭
Kestra Medical Technologies Ltd
전화
(425) 279-8002
주소
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
KMTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
25.86 | 1.45B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
525.04 | 187.46B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.40 | 57.96B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.87 | 39.68B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.31 | 37.32B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.50 | 37.29B | 5.26B | 1.44B | 1.76B | 9.7713 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | BTIG Research | Buy |
| 2025-03-31 | 개시 | BofA Securities | Buy |
| 2025-03-31 | 개시 | Goldman | Neutral |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-03-31 | 개시 | Stifel | Buy |
| 2025-03-31 | 개시 | Wells Fargo | Overweight |
| 2025-03-31 | 개시 | Wolfe Research | Outperform |
모두보기
Kestra Medical Technologies Ltd 주식(KMTS)의 최신 뉴스
Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Promising 16.84% Upside in the Healthcare Sector - directorstalkinterviews.com
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) versus Envista (NYSE:NVST) Head to Head Analysis - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpShould You Buy? - MarketBeat
Published on: 2026-01-21 23:54:20 - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares - Defense World
Short Interest in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Rises By 21.5% - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Sees Large Growth in Short Interest - MarketBeat
Should value investors consider Kestra Medical Technologies Ltd.July 2025 Trade Ideas & Weekly High Return Forecasts - bollywoodhelpline.com
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery - TradingView
Kestra Medical Technologies, Biobeat Technologies to Collaborate - Diagnostic and Interventional Cardiology
Kestra Medical partners with Biobeat to add blood pressure monitoring By Investing.com - Investing.com Nigeria
KMTS: Strong clinical data and innovation drive rapid growth and margin expansion in the WCD market - TradingView
Kestra Medical partners with Biobeat to add blood pressure monitoring - Investing.com
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery - GlobeNewswire
Market Rankings: Will Kestra Medical Technologies Ltd outperform its industry peersPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6% – What’s Next? - Defense World
Goldman Sachs Maintains Kestra Medical Technologies(KMTS.US) With Hold Rating, Raises Target Price to $27 - 富途牛牛
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6%Time to Sell? - MarketBeat
Is Kestra Medical Technologies Ltd. stock positioned for long term growthEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru
Will Kestra Medical Technologies Ltd. stock return to pre crisis levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth and 19% Potential Upside - directorstalkinterviews.com
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6.1% – Here’s Why - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6.1%Here's What Happened - MarketBeat
Traci Umberger Sells 10,500 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Brian Daniel Webster Sells 15,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Webster, Kestra medical CEO, sells $398k in shares By Investing.com - Investing.com Australia
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 10,500 Shares of Stock - MarketBeat
Kestra Medical Technologies Insider Sold Shares Worth $280,201, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies Insider Sold Shares Worth $398,847, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Both Private Equity Firms Who Control a Good Portion of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Along With Institutions Must Be Dismayed After Last Week's 3.1% Decrease - 富途牛牛
Biobeat Technologies Ltd. announced that it has received $50 million in funding from Ally Bridge Group, OrbiMed Advisors LLC, Elevage Medical Technologies, Kestra Medical Technologies, Ltd. and other investors - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Can Kestra Medical Technologies Ltd. stock maintain operating margins2025 Volume Leaders & AI Driven Stock Reports - Улправда
Will Kestra Medical Technologies Ltd. stock benefit from AI adoptionJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M - MSN
Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb? - Sahm
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Technologies reports strong earnings growth - MSN
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - Sahm
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Ltd (KMTS) 재무 분석
Kestra Medical Technologies Ltd (KMTS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.36%
0.01%
자본화:
|
볼륨(24시간):